COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20181208041886N2


Column Value
Trial registration number IRCT20181208041886N2
Full text link
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Dr. Mohsen Saniei

Contact
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

admin@exirpd.com

Registration date
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

2020-10-29

Recruitment status
Last imported at : Feb. 19, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Every body with positive COVID-19 Rt PCR Positive regard of the patient for cooperation

Exclusion criteria
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

age< 18 years old No compliance for drug consumption Very old age patients and the patients with mental disturbance which can not cooperate. the patients who use other chemical and/or traditional drugs the patients with underlying diseases such as Hypertention the patients who use antiseptic oral solutions the patients who use antiviral drugs

Number of arms
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Exir Danesh Asia Pharmaceutical company

Inclusion age min
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

No restriction on type of patients

Severity scale
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

0: No restriction on type of patients

Total sample size
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

60

primary outcome
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Negative COVID-19 Rt-PCR test after consuming the drug

Notes
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Not reported

Arms
Last imported at : Oct. 30, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 2192, "treatment_name": "Lidocaine+zinc", "treatment_type": "Central nervous system agents+vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]